APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $527,463 | -58.8% | 13,866 | -1.3% | 0.01% | -58.8% |
| Q2 2023 | $1,279,682 | +258.3% | 14,047 | +159.4% | 0.02% | +240.0% |
| Q1 2023 | $357,173 | +28.7% | 5,415 | +0.9% | 0.01% | +25.0% |
| Q4 2022 | $277,631 | -22.7% | 5,369 | +2.2% | 0.00% | -42.9% |
| Q3 2022 | $359,000 | +62.4% | 5,255 | +7.6% | 0.01% | +75.0% |
| Q2 2022 | $221,000 | -1.8% | 4,885 | +37.4% | 0.00% | 0.0% |
| Q2 2021 | $225,000 | – | 3,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
| Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
| SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
| Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
| HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
| CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
| Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
| Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
| Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
| Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |